Meanwhile, Stifel upgraded its Novartis AG [NVS] rating to a Buy from a a Hold in a research note published on Tuesday. A number of analysts have revised their coverage, including Credit Suisse’s analysts, who decreased its forecast for the stock in mid September from “a Neutral” to “an Underperform”. Berenberg also remained covering NVS and has decreased its forecast on September 14, 2022 with a “Hold” recommendation from previously “Buy” rating. Wolfe Research revised its rating on May 09, 2022. It rated NVS as “a Peer perform” which previously was an “an Outperform”.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Price Performance Review of NVS
On Tuesday, Novartis AG [NYSE:NVS] saw its stock fall -0.21% to $92.02. On the same session, the stock had its day’s lowest price of $87.00, but rose to a high of $92.13. Over the last five days, the stock has lost -0.39%. Novartis AG shares have risen nearly 1.43% since the year began. Nevertheless, the stocks have risen 5.73% over the past one year. While a 52-week high of $94.26 was reached on 01/18/23, a 52-week low of $74.09 was recorded on 01/24/23. SMA at 50 days reached $89.70, while 200 days put it at $85.35. A total of 2.72 million shares were traded, compared to the trading of 1.44 million shares in the previous session.
Levels Of Support And Resistance For NVS Stock
The 24-hour chart illustrates a support level at 88.64, which if violated will result in even more drops to 85.25. On the upside, there is a resistance level at 93.77. A further resistance level may holdings at 95.51. The Relative Strength Index (RSI) on the 14-day chart is 57.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.68%. Stochastics %K at 72.77% indicates the stock is a holding.
How much short interest is there in Novartis AG?
A steep rise in short interest was recorded in Novartis AG stocks on Oct 13, 2022, growing by 0.49 million shares to a total of 6.08 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 5.59 million shares. There was a rise of 8.06%, which implies that there is a positive sentiment for the stock.
Novartis AG [NVS] – Who Are The Largest Shareholders?
In filings from Dodge & Cox, it is revealed that the company now owns 21,048,657 shares, or roughly 0.88% of the outstanding NVS shares. In other words, the investor’s shares have fallen by -1,504,112 from its previous 13-F filing of 22552769.0. Additionally, PRIMECAP Management Co. decreased -0.86% of its stake after which the total value it holdings stand at $1,583,349,768, while Loomis, Sayles & Co. LP reduced -3.59% of its stake to hold $1.35 billion in the firm. Over the last quarter, Franklin Mutual Advisers LLC sold -288,168 shares of Novartis AG, while Dimensional Fund Advisors LP sold 465,677 shares. At present, Managed Account Advisors LLC is holding 5,534,681 shares valued at $502.11 million. Wellington Management Co. LLP owned 5,087,602 shares of the company at the time of its most recent 13F filing, worth $461.55 million.
According to FactSet, Novartis AG’s share price will average $95.60 in the next year, based on opinions of analysts polled by the firm. This is up nearly 2.45 percent from its previous closing price of $92.21. Analysts expect Novartis AG stock to reach the higher price of $114.03, while the lowest price estimate is $76.02. However, 26 analysts have rated NVS stock as a Hold in their predictions for 2023.